Neurobiology of Opioid Dependence: 2 - 2

Yale University

Status and phase: Withdrawn; Phase 2

Conditions: Opioid-Related Disorders

Treatments: Drug: Gamma hydroxybutyric

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000193

K20-00191-2

NIDA-00191-2

K20DA000191 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to evaluate the effects of gamma hydroxybutyric on naloxone-precipitated opiate withdrawal.

Sex: Male

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.